Siltuximab downregulates interleukin-8 and pentraxin 3 to improve ventilatory status and survival in severe COVID-19

Giuseppe Gritti; Federico Raimondi; Barbara Bottazzi; Diego Ripamonti; Ivano Riva; Francesco Landi; Leonardo Alborghetti; Marco Frigeni; Marianna Damiani; Caterina Micò; S. Fagiuoli; Ferdinando Luca Lorini; Lucia Gandini; Luca Novelli; Jonathan P. Morgan; Benjamin M. J. Owens; Karan Kanhai; Gordana Tonkovic Reljanovic; Marco Rizzi; Fabiano Di Marco; Alberto Mantovani; Alessandro Rambaldi

doi:10.1038/s41375-021-01299-x

Back

Siltuximab downregulates interleukin-8 and pentraxin 3 to improve ventilatory status and survival in severe COVID-19

Letter 2021 en

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2021

Correction: Siltuximab downregulates interleukin-8 and pentraxin 3 to improve ventilatory status and survival in severe COVID-19

Giuseppe Gritti, Federico Raimondi, Barbara Bottazzi, Diego Ripamonti, Ivano Riva, Francesco Landi, Leonardo Alborghetti, Marco Frigeni, Marianna Damiani, Caterina Micò, S. Fagiuoli, Ferdinando Luca Lorini, Lucia Gandini, Luca Novelli, Jonathan P. Morgan, Benjamin M. J. Owens, Karan Kanhai, Gordana Tonkovic Reljanovic, Marco Rizzi, Fabiano Di Marco, Alberto Mantovani, Alessandro Rambaldi

Letter2021

Circulating pentraxin 3 in severe COVID‐19 or other pulmonary sepsis

Alessandro Protti, Jennifer Meessen, Barbara Bottazzi, Cecília Garlanda, Angelo Milani, Monica Bacci, Alberto Mantovani, Maurizio Cecconi, Roberto Latini, Pietro Caironi

Preprint2025

Review: Age-adjusted non-COVID-19 mortality rates according to the COVID-19 vaccination status

John P A Ioannidis

Preprint2025

Review: Age-adjusted non-COVID-19 mortality rates according to the COVID-19 vaccination status

John P A Ioannidis

Preprint2025

Review: Age-adjusted non-COVID-19 mortality rates according to the COVID-19 vaccination status

John P A Ioannidis